These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24699413)

  • 1. The Batten disease gene CLN3 confers resistance to endoplasmic reticulum stress induced by tunicamycin.
    Wu D; Liu J; Wu B; Tu B; Zhu W; Luo J
    Biochem Biophys Res Commun; 2014 Apr; 447(1):115-20. PubMed ID: 24699413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
    Hersrud SL; Kovács AD; Pearce DA
    Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recessive
    Reith RR; Batt MC; Fuller AM; Meekins JM; Diehl KA; Zhou Y; Bedwell PS; Ward JA; Sanders SK; Petersen JL; Steffen DJ
    J Vet Diagn Invest; 2024 May; 36(3):438-446. PubMed ID: 38516801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLN3 deficiency leads to neurological and metabolic perturbations during early development.
    Heins-Marroquin U; Singh RR; Perathoner S; Gavotto F; Merino Ruiz C; Patraskaki M; Gomez-Giro G; Kleine Borgmann F; Meyer M; Carpentier A; Warmoes MO; Jäger C; Mittelbronn M; Schwamborn JC; Cordero-Maldonado ML; Crawford AD; Schymanski EL; Linster CL
    Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38195117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The parent and family impact of CLN3 disease: an observational survey-based study.
    Schulz A; Patel N; Brudvig JJ; Stehr F; Weimer JM; Augustine EF
    Orphanet J Rare Dis; 2024 Mar; 19(1):125. PubMed ID: 38500130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN).
    Brima T; Freedman EG; Prinsloo KD; Augustine EF; Adams HR; Wang KH; Mink JW; Shaw LH; Mantel EP; Foxe JJ
    J Neurodev Disord; 2024 Jan; 16(1):3. PubMed ID: 38183037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide signaling is disrupted in the yeast model for Batten disease.
    Osório NS; Carvalho A; Almeida AJ; Padilla-Lopez S; Leão C; Laranjinha J; Ludovico P; Pearce DA; Rodrigues F
    Mol Biol Cell; 2007 Jul; 18(7):2755-67. PubMed ID: 17475770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Protein Biomarker Discovery in CLN3.
    Dang Do AN; Sleat DE; Campbell K; Johnson NL; Zheng H; Wassif CA; Dale RK; Porter FD
    J Proteome Res; 2023 Jul; 22(7):2493-2508. PubMed ID: 37338096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and cellular basis of impaired phagocytosis and photoreceptor degeneration in CLN3 disease.
    Han J; Chear S; Talbot J; Swier V; Booth C; Reuben-Thomas C; Dalvi S; Weimer JM; Hewitt AW; Cook AL; Singh R
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased SNAI2 expression and defective collagen adhesion in cells with pediatric dementia, juvenile ceroid lipofuscinosis.
    Kim H; Bae S; Kim SJ
    Biochem Biophys Res Commun; 2024 Aug; 738():150561. PubMed ID: 39154552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor 84 gene expression is regulated by the ER stress response in the liver.
    Kanemoto S
    J Biochem; 2024 Jul; 176(1):55-68. PubMed ID: 38471516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium rescues the impaired autophagy process in CbCln3(Δex7/8/Δex7/8) cerebellar cells and reduces neuronal vulnerability to cell death via IMPase inhibition.
    Chang JW; Choi H; Cotman SL; Jung YK
    J Neurochem; 2011 Feb; 116(4):659-68. PubMed ID: 21175620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.
    Pavlou S; Foskolou S; Patikas N; Field SF; Papachristou EK; Santos C; Edwards AR; Kishore K; Ansari R; Rajan SS; Fernandes HJR; Metzakopian E
    Sci Rep; 2023 Mar; 13(1):3934. PubMed ID: 36894612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.
    Banerjee S; Ansari AA; Upadhyay SP; Mettman DJ; Hibdon JR; Quadir M; Ghosh P; Kambhampati A; Banerjee SK
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the lysosomal protein CLN3 modifies the lipid content of the nuclear envelope leading to DNA damage and activation of YAP1 pro-apoptotic signaling.
    Domingues N; Calcagni' A; Pires J; Freire SR; Herz NJ; Huynh T; Wieciorek K; Moreno MJ; Outeiro TF; Girão H; Milosevic I; Ballabio A; Raimundo N
    bioRxiv; 2024 Jun; ():. PubMed ID: 38853929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in
    Tarczyluk-Wells MA; Salzlechner C; Najafi AR; Lim MJ; Smith D; Platt FM; Williams BP; Cooper JD
    Front Neurol; 2019; 10():963. PubMed ID: 31572287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson's Disease Independent of Mutations in MAPT.
    Fernandes HJR; Kent JP; Bruntraeger M; Bassett AR; Koulman A; Metzakopian E; Snowden SG
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease.
    Johnson TB; Brudvig JJ; Likhite S; Pratt MA; White KA; Cain JT; Booth CD; Timm DJ; Davis SS; Meyerink B; Pineda R; Dennys-Rivers C; Kaspar BK; Meyer K; Weimer JM
    Front Genet; 2023; 14():1118649. PubMed ID: 37035740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.
    Grünewald B; Lange MD; Werner C; O'Leary A; Weishaupt A; Popp S; Pearce DA; Wiendl H; Reif A; Pape HC; Toyka KV; Sommer C; Geis C
    Elife; 2017 Nov; 6():. PubMed ID: 29135436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
    Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
    Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.